Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Abroad (travel likely)RecruitingPHASE2
Conditions
T-cell Acute Lymphoblastic Leukemia · T-cell Lymphoma · Mixed Phenotype Acute Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Rady Children's Hospital, San Diego, California, United States
Contact: Principal Investigator (Victor Wong, MD)Novant Health Presbyterian Hemby Children's Hospital, Charlotte, North Carolina, United States
Contact: Principal Investigator (Jessica Bell, MD)Saint Francis Children's Hospital, Tulsa, Oklahoma, United States
Contact: Principal Investigator (Ashraf Mohamed, MD)St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Seth E. Karol, MD, MSCI)
Study leads
Seth E. Karol, MD, MSCI
Principal Investigator
St. Jude Children's Research Hospital